‘Huge difference between potential market and current market to serve as gateway of opportunities for NIPT players’, says RNCOS.
Noida, UP -- (SBWIRE) -- 07/21/2014 -- Even though there has been tremendous growth in the NIPT market in the past few years, the players haven’t been able to tap the complete market. In 2013, the US NIPT market was estimated at US$ 165 Million whereas the potential market for high risk pregnancies was almost three times more than this figure. This indicates that till date only 35% of the high risk market has been tapped while much of it remains unexplored. This untapped potential can serve as a gateway for existing NIPT players as well as those who intend to foray into the NIPT market.
Our latest research report “US Non-Invasive Prenatal Testing Market Outlook 2018”, provides a prudent analysis on the current and future size of the market weighing the possible pessimistic and optimistic scenarios. In addition to it, the report has even mentioned the potential market for high and medium to high risk pregnancy patients. The demographic scenario of United States has been discussed with focus on the current and future number of births, with the demographics segregated by age and state.
It also provides a transparent view on the present regulatory framework elaborating on the existing loopholes. Our report has discussed the views of regulatory authorities, players and consumers towards the regulatory stringency and the direction of regulations in the future have also been covered.
Currently, the US NIPT sector is characterized by the presence of players like Sequenom, Verinata, Ariosa and Natera. These players have been profiled with their strengths and weaknesses and latest developments in the field of NIPT. The report is a must buy for new market entrants in the diagnostics field, planning to enter the prenatal segment.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM668.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.